Literature DB >> 32147898

Diabetes alters the involvement of myofibroblasts during periodontal wound healing.

Ignacio Retamal1, Romina Hernández2, Victoria Velarde3, Alejandro Oyarzún4, Constanza Martínez2, María Julieta González5, Jorge Martínez6, Patricio C Smith2.   

Abstract

OBJECTIVES: Myofibroblasts constitute a specific cell phenotype involved in connective tissue healing. Diabetes alters the wound healing response. However, it is not clear whether diabetes modifies the involvement of myofibroblasts in periodontal wounds.
MATERIALS AND METHODS: Type I diabetes was induced in rats through streptozotocin injection, and periodontal wounds were performed. Wound healing was evaluated histologically at 2, 5, 7, and 15 days by measuring epithelial migration, neutrophil infiltration, and collagen and biofilm formation. Distribution of myofibroblasts was evaluated through immunofluorescence for α-smooth muscle actin. Data analyses were performed using the Shapiro-Wilk, ANOVA, or Kruskal-Wallis tests.
RESULTS: Diabetic wounds were characterized by delayed epithelial closure, increased neutrophil infiltration, biofilm formation, and reduced collagen formation. Quantification of the myofibroblasts showed a significant reduction at 5 and 7 days in wounds of diabetic rats and an increase at 15 days when compared to wounds of non-diabetic rats.
CONCLUSIONS: Diabetic wound healing was associated with decreased epithelial and connective tissue healing, increased levels of inflammation, and biofilm formation. Myofibroblast differentiation was delayed in diabetic periodontal wounds at early time points. However, myofibroblasts persisted at later time points of healing. The present study suggests that diabetes alters the involvement of myofibroblasts during periodontal wound healing.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  collagen; diabetes; fibroblast; myofibroblast; periodontal healing

Year:  2020        PMID: 32147898     DOI: 10.1111/odi.13325

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  4 in total

1.  [Comparison of initial periodontal therapy and its correlation with white blood cell level in periodontitis patients with or without diabetes mellitus].

Authors:  X R Xu; P C Huo; L He; H X Meng; Y X Zhu; D S Jin
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-18

2.  Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway.

Authors:  Yi-Lin Zhang; Fen Liu; Zhi-Bang Li; Xiao-Tao He; Xuan Li; Rui-Xin Wu; Hai-Hua Sun; Shao-Hua Ge; Fa-Ming Chen; Ying An
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

Review 3.  Fibroblasts: Immunomodulatory factors in refractory diabetic wound healing.

Authors:  Ye Liu; Yiqiu Liu; Wenjie He; Xingrui Mu; Xingqian Wu; Junyu Deng; Xuqiang Nie
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

4.  Periodontal Treatment Protocol for Decompensated Diabetes Patients.

Authors:  Matías Dallaserra; Alicia Morales; Nayib Hussein; Marcela Rivera; Franco Cavalla; Mauricio Baeza; Franz J Strauss; Yazmin Yoma; Claudio Suazo; Gisela Jara; Johanna Contreras; Julio Villanueva; Francisca Valenzuela-Villarroel; Jorge Gamonal
Journal:  Front Oral Health       Date:  2021-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.